BlueDot
2013
FOUNDED
PRIVATE
STATUS
31-40
EMPLOYEES
Seed
LATEST DEAL TYPE
3
INVESTORS
Description
Developer of a global early warning system for infectious diseases. The company's healthcare technologies integrate expertise in clinical medicine, public health, and software development, enabling governments, businesses, healthcare workers, and individuals to gain tailored insights to help them get ahead of infectious disease risks from seasonal influenza to outbreaks like Zika or Ebola.
Website
Formerly Known As
BioDiaspora
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
- 209 Victoria Street
- Toronto, Ontario
- Canada
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BlueDot’s full profile, request a free trial.
BlueDot Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 02-Dec-2014 | 00000 | Completed | Generating Revenue | ||
| 2. Grant | 00000 | 00000 | Completed | Startup | ||
| 1. Seed Round | $400K | $400K | Completed | Startup |
BlueDot Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Horizons Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MaRS Innovation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Ontario Centres of Excellence | Government | Minority | 000 0000 | 000000 0 |
BlueDot Executive Team (7)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| James Yoon | Director, Design | ||
| Tom Wang | Director, Development | ||
| Lindsay Bryson | Director, Strategy and Operations | ||
| Kamran Khan | Founder |
3 Former Executives
You’re viewing 4 of 7 executives. Get the full list »